Ravenquest Biomed Stock Buy Hold or Sell Recommendation
Assuming the 90 days horizon and your highly speculative risk level, our recommendation regarding Ravenquest Biomed is 'Strong Sell'. Macroaxis provides Ravenquest Biomed buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding RVVQF positions.
Check out Ravenquest Biomed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Ravenquest and provide practical buy, sell, or hold advice based on investors' constraints. Ravenquest Biomed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
Ravenquest |
Execute Ravenquest Biomed Buy or Sell Advice
The Ravenquest recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ravenquest Biomed. Macroaxis does not own or have any residual interests in Ravenquest Biomed or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ravenquest Biomed's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Ravenquest Biomed Trading Alerts and Improvement Suggestions
| Ravenquest Biomed generated a negative expected return over the last 90 days | |
| Ravenquest Biomed has some characteristics of a very speculative penny stock | |
| The company has a current ratio of 0.48, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ravenquest Biomed until it has trouble settling it off, either with new capital or with free cash flow. So, Ravenquest Biomed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ravenquest Biomed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ravenquest to invest in growth at high rates of return. When we think about Ravenquest Biomed's use of debt, we should always consider it together with cash and equity. | |
| Ravenquest Biomed reported the revenue of 1.26 M. Net Loss for the year was (30.47 M) with profit before overhead, payroll, taxes, and interest of 801.29 K. | |
| Ravenquest Biomed has accumulated about 749.13 K in cash with (11.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Ravenquest Biomed Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ravenquest Biomed or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ravenquest Biomed's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ravenquest pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Ravenquest Biomed Volatility Alert
At this time Ravenquest Biomed exhibits very low volatility. You can indeed make money on Ravenquest instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Ravenquest Biomed Fundamentals Vs Peers
Comparing Ravenquest Biomed's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ravenquest Biomed's direct or indirect competition across all of the common fundamentals between Ravenquest Biomed and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ravenquest Biomed or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Ravenquest Biomed's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ravenquest Biomed by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ravenquest Biomed to competition |
| Fundamentals | Ravenquest Biomed | Peer Average |
| Return On Equity | -1.12 | -0.31 |
| Return On Asset | -0.19 | -0.14 |
| Operating Margin | (9.06) % | (5.51) % |
| Current Valuation | 11.72 M | 16.62 B |
| Shares Outstanding | 123.62 M | 571.82 M |
| Shares Owned By Insiders | 10.51 % | 10.09 % |
| Shares Owned By Institutions | 3.22 % | 39.21 % |
| Price To Book | 0.03 X | 9.51 X |
| Price To Sales | 0.03 X | 11.42 X |
| Revenue | 1.26 M | 9.43 B |
| Gross Profit | 801.29 K | 27.38 B |
| EBITDA | (27.26 M) | 3.9 B |
| Net Income | (30.47 M) | 570.98 M |
| Cash And Equivalents | 749.13 K | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Debt To Equity | 0.72 % | 48.70 % |
| Current Ratio | 0.49 X | 2.16 X |
| Book Value Per Share | 0.17 X | 1.93 K |
| Cash Flow From Operations | (11.1 M) | 971.22 M |
| Earnings Per Share | (0.22) X | 3.12 X |
| Number Of Employees | 15 | 18.84 K |
| Beta | -79.79 | -0.15 |
| Market Capitalization | 48.21 K | 19.03 B |
| Total Asset | 37.7 M | 29.47 B |
| Net Asset | 37.7 M |
About Ravenquest Biomed Buy or Sell Advice
When is the right time to buy or sell Ravenquest Biomed? Buying financial instruments such as Ravenquest Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ravenquest Biomed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sovereign ETFs Thematic Idea Now
Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sovereign ETFs theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Ravenquest Pink Sheet
Ravenquest Biomed financial ratios help investors to determine whether Ravenquest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ravenquest with respect to the benefits of owning Ravenquest Biomed security.